Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.
The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA vi...
Main Authors: | Kaneez Fatima, Shilu Mathew, Mohd Suhail, Ashraf Ali, Ghazi Damanhouri, Esam Azhar, Ishtiaq Qadri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4154687?pdf=render |
Similar Items
-
Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
by: Shilu Mathew, et al.
Published: (2015-01-01) -
Molecular docking and simulation of Zika virus NS3 helicase
by: Syed Lal Badshah, et al.
Published: (2019-05-01) -
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development
by: Luo, Dahai, et al.
Published: (2016) -
The Future of HCV Therapy: NS4B as an Antiviral Target
by: Hadas Dvory-Sobol, et al.
Published: (2010-11-01) -
Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent.
by: Hyock Joo Kwon, et al.
Published: (2015-01-01)